In the question below, are given a statement followed by three courses of actions numbered I, II and III. On the basis of the information given, you have to assume everything in the statement to be true, and then decide which of the suggested course of action logically follow (s) for pursuing. Statement: Drugmaker Mankind Pharma is looking at achieving a turnover of USD 1 billion by 2021 from the present Rs 5,200 crore. The company is also looking at increasing its exports substantially to USD 100-150 USD million in the next three years from the present USD 10 million. Courses of action: I. Mankind Pharma’s current turnover is Rs 5,200 crore and will touch USD 1 billion by 2021 as we target higher growth in both the domestic as well as international markets. II. Mankind Pharma will continue to focus on domestic market which is still growing at a CAGR of 8-10 per cent with special focus on regions where it is not strong and there is tremendous potential to grow. It will continue to focus on chronic segment/lifestyle diseases which are growing markets here and generates long-term prescriptions. III. It has a significant presence in Southeast Asia, Africa and the CIS markets. It has recently ventured into the US market with the filing of 12-15 ANDAs every year.
In the question below, are given a statement followed by three courses of actions numbered I, II and III. On the basis of the information given, you have to assume everything in the statement to be true, and then decide which of the suggested course of action logically follow (s) for pursuing. Statement: Drugmaker Mankind Pharma is looking at achieving a turnover of USD 1 billion by 2021 from the present Rs 5,200 crore. The company is also looking at increasing its exports substantially to USD 100-150 USD million in the next three years from the present USD 10 million. Courses of action: I. Mankind Pharma’s current turnover is Rs 5,200 crore and will touch USD 1 billion by 2021 as we target higher growth in both the domestic as well as international markets. II. Mankind Pharma will continue to focus on domestic market which is still growing at a CAGR of 8-10 per cent with special focus on regions where it is not strong and there is tremendous potential to grow. It will continue to focus on chronic segment/lifestyle diseases which are growing markets here and generates long-term prescriptions. III. It has a significant presence in Southeast Asia, Africa and the CIS markets. It has recently ventured into the US market with the filing of 12-15 ANDAs every year. Correct Answer Neither I nor III follows
A course of action is something that needs to be done considering the present scenario in mind.
The given statement is about Drugmaker Mankind Pharma which is planning to stretch its claws in the market and achieve the desired turnover. Thus, it must work accordingly, in order to achieve that and that actions that will be followed in the process of achieving the task will be our courses of action.
From the courses of actions discussed we can infer that,
Course of action (I) states that the company is planning to do something but how, is not mentioned. Thus, it is not relevant.
Course of action (II) lays down plausible courses of action that the company might undertake in order to achieve the desired goal.
Course of action (III) mentions the reasons that can be attributed to the growth of the company but does not list any course of action, thus, it is rejected.
Thus, the correct answer is option 2 and rest of the option choices can be rejected.